Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Sell

Wall Street Data Solutions Rating

Neutral

B

Advantage Solutions Inc. Class A Common Stock (ADV)

Services-business Services, Nec

https://www.advantagesolutions.net

Advantage Solutions Inc is the provider of outsourced sales and marketing solutions to consumer goods companies and retailers. It has a technology-enabled platform of sales and marketing services like headquarter sales, retail merchandising, in-store sampling, digital commerce, and shopper marketing. For brands and retailers of all sizes, the firm helps to get the right products on the shelf and into the hands of consumers. The company helps its clients to sell more while spending less. Advantage has offices throughout North America and strategic investments in select markets throughout Africa, Asia, Australia, and Europe through which it services the global needs of multinational, regional, and local manufacturers. Its services are provided across two segments sales and marketing.

15310 BARRANCA PARKWAY, SUITE 100
IRVINE, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/29/2020

Market Cap

1,149,128,730

Shares Outstanding

326,390,000

Weighted SO

326,393,598

Total Employees

N/A

Upcoming Earnings

08/02/2024

Similar Tickers

CRTO --.--%

DLX --.--%

EEX --.--%

MCHX --.--%

IAS --.--%

EVC --.--%

DRCT --.--%

CMPR --.--%

TSQ --.--%

Beta

1.5600

Last Div

0.0000

Range

1.85-4.95

Chg

-0.0150

Avg Vol

1077533

Mkt Cap

1149128730

Exch

NASDAQ

Country

US

Phone

949 797 2900

DCF Diff

-0.1502

DCF

3.7552

Div Yield

0.0000

P/S

0.2925

EV Multiple

11.1047

P/FV

1.1803

Div Yield %

0.0000

P/E

-6.3150

PEG

-1.7702

Payout

-0.0070

Current Ratio

2.1154

Quick Ratio

2.1154

Cash Ratio

0.3328

DSO

60.1552

DIO

0.0000

Op Cycle

60.1552

DPO

21.1510

CCC

39.0043

Gross Margin

0.0998

Op Margin

0.0088

Pretax Margin

-0.0557

Net Margin

-0.0466

Eff Tax Rate

0.2368

ROA

-0.0524

ROE

-0.1723

ROCE

0.0115

NI/EBT

0.8374

EBT/EBIT

-6.3561

EBIT/Rev

0.0088

Debt Ratio

0.5077

D/E

1.8112

LT Debt/Cap

0.6426

Total Debt/Cap

0.6443

Int Coverage

0.2173

CF/Debt

0.1039

Equity Multi

3.5672

Rec Turnover

6.0676

Pay Turnover

17.2569

Inv Turnover

999999.9999

FA Turnover

45.2231

Asset Turnover

1.1232

OCF/Share

0.5714

FCF/Share

0.4079

Cash/Share

0.5247

OCF/Sales

0.0470

FCF/OCF

0.7140

CF Coverage

0.1039

ST Coverage

13.8929

CapEx Coverage

3.4964

Div&CapEx Cov

3.4138

P/BV

1.1803

P/B

1.1803

P/S

0.2925

P/E

-6.3150

P/FCF

8.7267

P/OCF

6.2746

P/CF

6.2746

PEG

-1.7702

P/S

0.2925

EV Multiple

11.1047

P/FV

1.1803

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Apr 08, 22:15 Matthews Asia Co-Founder Mark Headley Returns as Executive Chairman GlobeNewswire Inc. Nov 10, 10:00 Advantage Solutions named Corporate Champion by the Women’s Forum of New York GlobeNewswire Inc. Nov 04, 17:54 Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023 GlobeNewswire Inc. Nov 04, 17:54 Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023 GlobeNewswire Inc. Nov 04, 17:54 Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023 GlobeNewswire Inc. Nov 04, 17:54 Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023 GlobeNewswire Inc. Nov 04, 17:54 Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023 GlobeNewswire Inc. Nov 04, 17:54 Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023 GlobeNewswire Inc. Nov 04, 17:54 Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023 GlobeNewswire Inc. Nov 04, 17:54 Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023 GlobeNewswire Inc. Nov 04, 17:54 Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023 GlobeNewswire Inc. Nov 04, 17:54 Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023 GlobeNewswire Inc. Nov 04, 17:54 Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023 GlobeNewswire Inc. Nov 04, 17:54 Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023 GlobeNewswire Inc. Nov 04, 17:54 Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023 GlobeNewswire Inc. Nov 04, 17:54 Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023 GlobeNewswire Inc. Oct 30, 13:00 Crisp Acquires Atlas Technology Group from Advantage Solutions to Empower CPG Brands with Better Data GlobeNewswire Inc. Oct 23, 10:19 Advantage Solutions Announces Third Quarter 2023 Financial Results Release Date and Conference Call GlobeNewswire Inc. Oct 23, 10:19 Advantage Solutions Announces Third Quarter 2023 Financial Results Release Date and Conference Call

Revenue Product Segmentation